EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation

Figure 6

Correlation between EFNB1 expression levels and its immunomodulators. (a) EFNB1-related immunoinhibitors. (b) EFNB1-related immunostimulators.

(a)

(b)